Introduction. Risk factors for thrombotic events in patients receiving
treatment for Hodgkin lymphoma are not well known. Administration of some
cytostatic medication, especially via central venous catheter,
corticosteroids and hyperlipidemia can present some of them. Case outline.
A case of a 15-year-old boy that had been newly diagnosed with Hodgkin
lymphoma is presented here. Chemotherapy according to vincristine,
etoposide, prednisone, and doxorubicin (OEPA) protocol was introduced a
month before headache and vomiting occurred, so subsequently, brain-
computer tomography (CT) was performed, and reviled laminar subdural pseudo
hemorrhage in the right occipital region. After performing magnet resonance
imaging (MRI) venous thrombosis of the posterior part of superior sagittal
sinus, right transverses and sigmoid sinus were presented.
Low-molecular-weight heparin (LMWH) and anti-edematous therapy was
immediately initiated. Two weeks later the patient resumed the second cycle
of chemotherapy combined with LMWH, as the previous symptoms of intracranial
hypertension resolved. Two years after MRI showed almost complete resolution
of finding. The boy was in good clinical condition. Conclusion. Although
administration of oral corticosteroids, could be rarely a risk factor per se
for cerebral sinus venous thrombosis in HL patients, it remains important
treatment option. Adequate and prompt diagnostics and therapy are mandatory
in cases of wide intracranial venous thrombosis as prevention of possible
intracranial hypertension and even fatal outcome.